Laufey Tryggvadottir

Professor

University of Iceland
Country flagIceland
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (2)

Background and purpose: Organised mammography screening reduces breast cancer mortality by 30–40% in women aged 50–69. Despite limited evidence for women aged 40–49, screening guidelines are trending toward younger ages. Iceland has offered biennial screening to women aged 40–69 since 1987. This study compares screening quality indicators and tumour characteristics between women aged 40–49 and 50–69 from 1990 to 2020. Patient/material and methods: Screening-related data were obtained from the Icelandic Breast Cancer Screening Program, and breast cancer diagnoses and tumour characteristics were sourced from the Icelandic Cancer Registry. Results: In total, 84,677 women aged 40–69 years attended 455,532 organised screening sessions in Iceland over a 30-year period. Women aged 40–49 years demonstrated higher recall rates (4.9% vs. 3.5%) and lower participation rates (60.7% vs. 61.5%), lower breast cancer detection rates (2.1 vs. 6.0/1,000), and lower episode sensitivity (54.8% vs. 70.5%), compared to those aged 50–69 years. Among screen-detected cases, women aged 40–49 years exhibited a higher proportion of tumours larger than 20 mm (29.7% vs. 21.7%), more lymph node positivity (41.2% vs. 28.2%) and higher human epidermal growth factor receptor 2 (HER2) positivity (18.6% vs. 11.8%), compared to those aged 50–69 years. Interpretation: The disparity in breast cancer screening performances between the age groups may reflect unmodifiable factors in younger women. The presence of advanced tumour characteristics among women aged 40–49 years who attended screening indicates the importance of early detection for improving prognosis.

Year:

2025

Two-thirds of all human conceptions are lost, in most cases before clinical detection. The lack of detailed understanding of the causes of pregnancy losses constrains focused counseling for future pregnancies. We have previously shown that a missense variant in synaptonemal complex central element protein 2 ( SYCE2 ), in a key residue for the assembly of the synaptonemal complex backbone, associates with recombination traits. Here we show that it also increases risk of pregnancy loss in a genome-wide association analysis on 114,761 women with reported pregnancy loss. We further show that the variant associates with more random placement of crossovers and lower recombination rate in longer chromosomes but higher in the shorter ones. These results support the hypothesis that some pregnancy losses are due to failures in recombination. They further demonstrate that variants with a substantial effect on the quality of recombination can be maintained in the population.

Year:

2024

Collaborators (12)

Søren Brunak

Professor of Disease Systems Biology, Research Director

Københavns Universitet

DENMARK
View details

Karina Banasik

Associate Professor

Technical University of Denmark

DENMARK
View details

Sisse Rye Ostrowski

Københavns Universitet

DENMARK
View details

David Westergaard

Associate Professor

Technical University of Denmark

DENMARK
View details

H S Nielsen

Professor

Copenhagen University Hospital

DENMARK
View details

Kari Stefansson

Professor

University of Iceland

ICELAND
View details

Christian Erikstrup

Chair Professor

Aarhus University

DENMARK
View details

Mette Nyegaard

Head of Department

Aalborg University

DENMARK
View details

Ásgeir Haraldsson

-

ICELAND
View details

Thomas Folkmann Hansen

Professor

Technical University of Denmark

DENMARK
View details

Ole Birger Pedersen

Professor

Zealand University Hospital

DENMARK
View details

Eva Hoffmann

Professor

Københavns Universitet

DENMARK
View details